Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Fort

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Rheumatology|May 1, 1994
Muscle involvement in polyarteritis nodosa: report of a patient presenting clinically as polymyositis and review of the literatureJ G Fort, R Griffin, A Tahmoush, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2010
Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteersP Miner, J Plachetka, E Orlemans, et al.
The Journal of Rheumatology|March 1, 1992
B cell surface marker analysis of synovial fluid cells in a patient with monoarthritis and chronic lymphocytic leukemiaJ G Fort, C Fernandez, S R Jacobs, et al.
The Journal of Ambulatory Care Management|July 4, 2001
How the health care system can improve mammography-screening rates for underserved women: a closer look at the health care delivery systemN U Ahmed, J G Fort, T H Micah, et al.
Arthritis and Rheumatism|July 1, 1987
Anticardiolipin antibodies in patients with rheumatic diseasesJ G Fort, F S Cowchock, J L Abruzzo, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 14, 2006
COX-2 specific inhibitors in the management of osteoarthritis of the knee: a placebo-controlled, randomized, double-blind studyF McKenna, A Weaver, J J Fiechtner, et al.
Alimentary Pharmacology & Therapeutics|May 26, 2010
Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen aloneJ L Goldstein, M C Hochberg, J G Fort, et al.
American Journal of Therapeutics|April 17, 2001
Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patientsA Whelton, J G Fort, J A Puma, et al.
The American Journal of Gastroenterology|February 1, 1996
Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter studyJ B Raskin, R H White, R Jaszewski, et al.
Clinical Therapeutics|March 25, 1999
Health-related quality-of-life effects of oxaprozin and nabumetone in patients with osteoarthritis of the kneeS Z Zhao, S D Dedhiya, T S Bocanegra, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Rheumatology|May 1, 1994
Muscle involvement in polyarteritis nodosa: report of a patient presenting clinically as polymyositis and review of the literatureJ G Fort, R Griffin, A Tahmoush, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2010
Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteersP Miner, J Plachetka, E Orlemans, et al.
The Journal of Rheumatology|March 1, 1992
B cell surface marker analysis of synovial fluid cells in a patient with monoarthritis and chronic lymphocytic leukemiaJ G Fort, C Fernandez, S R Jacobs, et al.
The Journal of Ambulatory Care Management|July 4, 2001
How the health care system can improve mammography-screening rates for underserved women: a closer look at the health care delivery systemN U Ahmed, J G Fort, T H Micah, et al.
Arthritis and Rheumatism|July 1, 1987
Anticardiolipin antibodies in patients with rheumatic diseasesJ G Fort, F S Cowchock, J L Abruzzo, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 14, 2006
COX-2 specific inhibitors in the management of osteoarthritis of the knee: a placebo-controlled, randomized, double-blind studyF McKenna, A Weaver, J J Fiechtner, et al.
Alimentary Pharmacology & Therapeutics|May 26, 2010
Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen aloneJ L Goldstein, M C Hochberg, J G Fort, et al.
American Journal of Therapeutics|April 17, 2001
Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patientsA Whelton, J G Fort, J A Puma, et al.
The American Journal of Gastroenterology|February 1, 1996
Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter studyJ B Raskin, R H White, R Jaszewski, et al.
Clinical Therapeutics|March 25, 1999
Health-related quality-of-life effects of oxaprozin and nabumetone in patients with osteoarthritis of the kneeS Z Zhao, S D Dedhiya, T S Bocanegra, et al.
Pageof 3